Results 51 to 60 of about 31,420 (68)

Targeting KRAS Mutant Cancers with a Covalent G12C-Specific Inhibitor

Cell, 2018
Lian-Sheng Li, Patrick P Zarrinkar, Matthew R Janes   +2 more
exaly  

Oncogenic KRAS Regulates Amino Acid Homeostasis and Asparagine Biosynthesis via ATF4 and Alters Sensitivity to L-Asparaginase

Cancer Cell, 2018
Tina Cowan, Davide Ruggero, Eric Sweet-Cordero   +2 more
exaly  

KRAS-IRF2 Axis Drives Immune Suppression and Immune Therapy Resistance in Colorectal Cancer

Cancer Cell, 2019
Michael J Overman, Jianhua Zhang, Krittiya Korphaisarn   +2 more
exaly  

KRAS Alleles: The Devil Is in the Detail

Trends in Cancer, 2017
Kevin M Haigis
exaly  

Mutant KRAS Enhances Tumor Cell Fitness by Upregulating Stress Granules

Cell, 2016
Elda Grabocka, Dafna Bar-Sagi
exaly  

KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab

Annals of Oncology, 2008
Nicola Personeni, Hubert Piessevaux, J -L van Laethem   +2 more
exaly  

Selumetinib with and without erlotinib in KRAS mutant and KRAS wild-type advanced nonsmall-cell lung cancer†

Annals of Oncology, 2016
Giuseppe Giaccone, K L Reckamp, S M Steinberg   +2 more
exaly  

Contact karst of Southern Velebit (Croatia): Kontaktni kras južnega Velebita (Hrvaška):

2001
Buzjak, Nenad, Perica, Dražen
openaire   +1 more source

Targeting the untargetable KRAS in cancer therapy

Acta Pharmaceutica Sinica B, 2019

exaly  

Pharmacological Induction of RAS-GTP Confers RAF Inhibitor Sensitivity in KRAS Mutant Tumors

Cancer Cell, 2018
Joachim Rudolph, Shiva Malek, Mark Merchant   +2 more
exaly